Kai Dong1, Lei Liu2, Zhipeng Yu1, Di Wu3, Qian Zhang1, Xiaoqin Huang1, Jianping Ding1, Haiqing Song1. 1. Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China. 2. Department of Thoracic Surgerye, Xuanwu Hospital, Capital Medical University, Beijing 100053, China. 3. China-America Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Abstract
BACKGROUND: To investigate the neuropsychiatric symptoms and their treatment and outcomes in lung cancer patients with brain metastases (BM), with an attempt to achieve early detection and prompt management of these symptoms. METHODS: Ten lung cancer patients (8 males and 2 females) with BMs who were treated in our center from 2013 to 2019 were enrolled in this analysis. Without exception, all 10 patients presented with chief complaints of neuropsychiatric symptoms, and BMs were eventually diagnosed. Appropriate treatments were offered, and all patients were followed up. RESULTS: Two patients died (case 5 died of sudden massive hemoptysis, and case 6 died after his families refused to receive the invasive treatment). Data on 3- and 5-year survival have been obtained from one patient each. The average follow-up duration was 19.4 months (except that two patients were hospitalized only once, and one patient received the second follow-up visit only 9 days after the first visit). CONCLUSIONS: The possibility of BM from lung cancer should be considered when a lung cancer patient develops neuropsychiatric symptoms, and timely diagnosis treatment should be arranged accordingly. 2019 Translational Lung Cancer Research. All rights reserved.
BACKGROUND: To investigate the neuropsychiatric symptoms and their treatment and outcomes in lung cancer patients with brain metastases (BM), with an attempt to achieve early detection and prompt management of these symptoms. METHODS: Ten lung cancer patients (8 males and 2 females) with BMs who were treated in our center from 2013 to 2019 were enrolled in this analysis. Without exception, all 10 patients presented with chief complaints of neuropsychiatric symptoms, and BMs were eventually diagnosed. Appropriate treatments were offered, and all patients were followed up. RESULTS: Two patients died (case 5 died of sudden massive hemoptysis, and case 6 died after his families refused to receive the invasive treatment). Data on 3- and 5-year survival have been obtained from one patient each. The average follow-up duration was 19.4 months (except that two patients were hospitalized only once, and one patient received the second follow-up visit only 9 days after the first visit). CONCLUSIONS: The possibility of BM from lung cancer should be considered when a lung cancer patient develops neuropsychiatric symptoms, and timely diagnosis treatment should be arranged accordingly. 2019 Translational Lung Cancer Research. All rights reserved.
Authors: Inan Olmez; Bernadine R Donahue; James S Butler; Yiwu Huang; Philip Rubin; Yiqing Xu Journal: Lung Cancer Date: 2010-03-06 Impact factor: 5.705
Authors: L Gaspar; C Scott; M Rotman; S Asbell; T Phillips; T Wasserman; W G McKenna; R Byhardt Journal: Int J Radiat Oncol Biol Phys Date: 1997-03-01 Impact factor: 7.038
Authors: Laurie E Gaspar; Minesh P Mehta; Roy A Patchell; Stuart H Burri; Paula D Robinson; Rachel E Morris; Mario Ammirati; David W Andrews; Anthony L Asher; Charles S Cobbs; Douglas Kondziolka; Mark E Linskey; Jay S Loeffler; Michael McDermott; Tom Mikkelsen; Jeffrey J Olson; Nina A Paleologos; Timothy C Ryken; Steven N Kalkanis Journal: J Neurooncol Date: 2009-12-04 Impact factor: 4.130
Authors: J Lee Villano; Eric B Durbin; Chris Normandeau; Jigisha P Thakkar; Valentina Moirangthem; Faith G Davis Journal: Neuro Oncol Date: 2014-06-02 Impact factor: 12.300
Authors: Nicola L Ainsworth; Mary A McLean; Dominick J O McIntyre; Davina J Honess; Anna M Brown; Susan V Harden; John R Griffiths Journal: Magn Reson Med Date: 2016-06-09 Impact factor: 4.668
Authors: Fei Lu; Yu Hou; Yaoxiong Xia; Lan Li; Li Wang; Ke Cao; Haixia Chen; Li Chang; Wenhui Li Journal: Cancer Manag Res Date: 2019-05-08 Impact factor: 3.989